EP. 1: Dr Lucio Gordan Outlines the Treatment Paradigm for KRAS-Positive NSCLC
February 6th 2023Being able to treat patients with non–small cell lung cancer (NSCLC) and a KRAS mutation with sotorasib has been exciting, and now there’s another drug available with the approval of adagrasib at the end of 2022, explained Lucio Gordan, MD, of Florida Cancer Specialists & Research Institute.
Read More
EP. 2: Dr Alexander Spira on Unmet Needs, Treatments for KRAS-Mutated NSCLC
October 14th 2022Alexander Spira, MD, PhD, a medical oncologist and director of VCS Research Institute & Phase I Trial Program, Virginia Cancer Specialists, discusses unmet needs and treatment with KRAS-mutated non–small cell lung cancer (NSCLC).
Read More